Vestal Point Capital’s Arvinas ARVN Stock Holding History

Vestal Point Capital’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-905,465	Closed	-$9.6M	–	72
2026 Q1	$9.6M	Buy	+905,465	New	+$11.2M	0.27%	66

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestal Point Capital's ARVN Position: Q2 2026 in Review

Vestal Point Capital sold out of Arvinas (ARVN) in Q2 2026, closing a stake of 905,465 shares — an estimated $9.6M sold.

Vestal Point Capital first reported a position in ARVN in Q1 2026 and held it in 1 quarter. The position peaked at $9.6M in Q1 2026. 201 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

Vestal Point Capital reported no remaining Arvinas position as of Q2 2026 after selling out during the quarter.
Vestal Point Capital sold 905,465 Arvinas shares in Q2 2026, an estimated $9.6M.
Vestal Point Capital first reported a position in Arvinas in Q1 2026 and held it in 1 quarter.
Vestal Point Capital's Arvinas position peaked at $9.6M in Q1 2026.
201 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.